June 16, 2023 3:50 PM | 1 min read
The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) signaled its support for removing cannabis from the Association’s banned substances list and testing protocols.
For cannabis to be removed from the list, each of the three divisional governance bodies of the NCAA needs to introduce and adopt legislation, noted an NCAA press release on Friday.
The committee will also seek support from the NCAA Board of Governors to stop testing for cannabis at NCAA championship events while legislative action is considered.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you’ll also get Benzinga’s ultimate morning update AND a free $30 gift card and more!
Not A Performance-Enhancing Drug
Following an NCAA decision to adopt more lenient cannabis policies in February 2022, the rationale for considering the change was largely informed by the December 2022 Summit on Cannabinoids in College Athletics and includes the consensus opinion that cannabis is not a performance-enhancing drug and that a harm reduction approach to cannabis is best implemented at the college level.
“The Best Report Benzinga Has Ever Produced”
Massive returns are possible within this market! For a limited time, get access to the Benzinga Insider Report, usually $47/month, for just $0.99! Discover extremely undervalued stock picks before they skyrocket! Time is running out! Act fast and secure your future wealth at this unbelievable discount! Claim Your $0.99 Offer NOW!
Advertorial
After all, the NBA is no longer testing its players for cannabis as part of a deal between the league and the National Basketball Players Association.
Major League Baseball stopped testing players for cannabis several years ago. They did however add synthetic cannabinoids, cocaine, opioids and fentanyl to the list of prohibited drugs that they test for.
In addition to the policy and testing changes, CSMAS also signaled its support for the development of a comprehensive communication and education campaign that provides guidance to the membership about cannabis.
Photo by Logan Weaver on Unsplash
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Be the first to comment